drugset / Trial / NCT01648179
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is an open-label, randomized, single dose, four period, balanced crossover study to assess in eligible healthy male or female subjects.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LANOPEPDEN | Small molecule | 1500 mg | Intravenous |